Literature DB >> 18820926

[Molecular mechanisms and consequences of cardiac viral infections].

R Kandolf1, B Bültmann, K Klingel, C-T Bock.   

Abstract

Molecular biological methods have confirmed the pathogenetic role of enteroviruses, primarily coxsackieviruses of group B (CVB), in the induction and maintenance of inflammatory cardiomyopathy. More recently, adenoviruses, various herpes viruses, and increasingly parvovirus B19 (B19) have been identified as potential cardiotropic agents. While cardiac myocytes are target cells for enterovirus and adenovirus infections with virus-induced cytolysis, B19-associated inflammatory cardiomyopathy is characterized by infection of intracardiac endothelial cells of small arterioles and veins, which may be associated with endothelial dysfunction, impairment of myocardial microcirculation, penetration of inflammatory cells, and secondary myocyte necrosis. Recent observations showed that B19 is involved in intracellular calcium regulation by the viral phospholipase. B19-induced caspase activation can lead to proinflammatory/proapoptotic processes through dysregulation of STAT signaling. These cellular interactions may contribute to mechanisms by which B19 establishes persistent infection in endothelial cells and play a critical role in viral pathogenesis of inflammatory cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820926     DOI: 10.1007/s00292-008-1027-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  21 in total

Review 1.  Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system.

Authors:  R Kandolf; M Sauter; C Aepinus; J J Schnorr; H C Selinka; K Klingel
Journal:  Virus Res       Date:  1999-08       Impact factor: 3.303

2.  Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

Authors:  C Badorff; G H Lee; B J Lamphear; M E Martone; K P Campbell; R E Rhoads; K U Knowlton
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

3.  Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1.

Authors:  Adrian Lupescu; C-Thomas Bock; Philipp A Lang; Susanne Aberle; Heike Kaiser; Reinhard Kandolf; Florian Lang
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

4.  Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy.

Authors:  I M Grumbach; A Heim; P Pring-Akerblom; S Vonhof; W J Hein; G Müller; H R Figulla
Journal:  Acta Cardiol       Date:  1999-04       Impact factor: 1.718

Review 5.  Fifth (human parvovirus) and sixth (herpesvirus 6) diseases.

Authors:  W C Koch
Journal:  Curr Opin Infect Dis       Date:  2001-06       Impact factor: 4.915

Review 6.  [Virus etiology of inflammatory cardiomyopathy].

Authors:  R Kandolf
Journal:  Dtsch Med Wochenschr       Date:  2004-10-08       Impact factor: 0.628

Review 7.  Molecular pathology of inflammatory cardiomyopathy.

Authors:  Karin Klingel; Martina Sauter; C Thomas Bock; Gudrun Szalay; Jens-Jörg Schnorr; Reinhard Kandolf
Journal:  Med Microbiol Immunol       Date:  2003-08-14       Impact factor: 3.402

8.  Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.

Authors:  R Wessely; K Klingel; L F Santana; N Dalton; M Hongo; W Jonathan Lederer; R Kandolf; K U Knowlton
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

9.  Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.

Authors:  Anja Duechting; Carsten Tschöpe; Heike Kaiser; Tobias Lamkemeyer; Nobuyuki Tanaka; Susanne Aberle; Florian Lang; Joseph Torresi; Reinhard Kandolf; C-Thomas Bock
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

10.  Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry.

Authors:  Kirsten A Weigel-Kelley; Mervin C Yoder; Arun Srivastava
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  4 in total

1.  Molecular phenotypes of human parvovirus B19 in patients with myocarditis.

Authors:  C-Thomas Bock; Anja Düchting; Friederike Utta; Eva Brunner; Bui Tien Sy; Karin Klingel; Florian Lang; Meinrad Gawaz; Stephan B Felix; Reinhard Kandolf
Journal:  World J Cardiol       Date:  2014-04-26

Review 2.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 3.  Inflammatory dilated cardiomyopathy : Etiology and clinical management.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Herz       Date:  2020-05       Impact factor: 1.443

4.  Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure.

Authors:  Heiko Pietsch; Felicitas Escher; Ganna Aleshcheva; Dirk Lassner; Claus-Thomas Bock; Heinz-Peter Schultheiss
Journal:  Sci Rep       Date:  2020-12-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.